Combination of cyclosporin A and buthionine sulfoximine (BSO) as a pharmacological strategy for circumvention of multidrug resistance in small cell lung cancer cell lines selected for resistance to doxorubicin (Q41703955)
scientific article published on January 1, 1991
Language:
Current Data About Combination of cyclosporin A and buthionine sulfoximine (BSO) as a pharmacological strategy for circumvention of multidrug resistance in small cell lung cancer cell lines selected for resistance to doxorubicin
(P31) (Q13442814)
(P248)
(P698) 1850223
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1850223%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 19, 2019

(P50) (Q66206609)
(P1545) 1
(P1932) Larsson R
(P248)
(P698) 1850223
(P813) Saturday, October 7, 2017

(Q66206118)
(P1545) 3
(P1932) Nygren P
(P248)
(P698) 1850223
(P813) Saturday, October 7, 2017

(P304) 455-459
(P248)
(P698) 1850223
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1850223%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 19, 2019

(P407) (Q1860)

(P433) 1
(P248)
(P698) 1850223
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1850223%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 19, 2019

(P478) 11
(P248)
(P698) 1850223
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1850223%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 19, 2019

(P577) Tuesday, January 1, 1991
(P248)
(P698) 1850223
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1850223%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 19, 2019

(P921) (Q643839)
(P887)

(Q367700)
(P887)

(P1433) (Q326290)
(P248)
(P698) 1850223
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1850223%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 19, 2019

(P1476) "Combination of cyclosporin A and buthionine sulfoximine (BSO) as a pharmacological strategy for circumvention of multidrug resistance in small cell lung cancer cell lines selected for resistance to doxorubicin" (language: en)
(P248)
(P698) 1850223
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1850223%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 19, 2019

(P2093) J. Bergh
(P1545) 2
(P248)
(P698) 1850223
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1850223
(P813) Friday, December 9, 2022

other details
description scientific article published on January 1, 1991

External Links
(P698) 1850223